Scientific facilitation groups
Our agency brings people together within a variety of groups, such as Coordinated Actions (CAs), workgroups and sub-groups, networks, and task forces.
Last updated on 06 March 2025
Objective
The objective is to promote interactions between researchers from different institutions or disciplines, and representatives of patient organisations. These facilitation meetings help to stimulate reflection on specific topics, encourage research collaboration and the design of innovative projects, highlight priority areas for research or, on the contrary, areas that receive less attention and yet are necessary.
Coordinated actions
Coordinated Action on Host-Virus Interactions: Basic and Translational HIV Research (CA41)
This Coordinated Action drives research into the mechanisms regulating HIV replication and persistence, the induction of effective immune responses and remission of infection through patient cohorts and animal models, with the aim of developing curative therapies.
Coordinated Action on Viral Hepatitis Basic and Translational Research (CA42)
This Coordinated Action drives basic and translational research in the field of viral hepatitis. It explores new areas of interest, establishes future directions and supports researchers in the maturation of their projects.
Coordinated Action on Public Health, HIV, Sexual Health and Hepatitis (CA46)
This Coordinated Action takes a multidisciplinary approach to a wide range of research topics in public health, HIV, sexual health and hepatitis, in France and internationally.
Coordinated Action on Infectious Diseases Modelling (CA49)
Modelling has become an essential tool for understanding infectious dynamics, at both individual and population levels.
Coordinated Action Tuberculosis
The Coordinated Action aims to facilitate the establishment of collaborative projects, strengthen R&D and propose new diagnostic, therapeutic and vaccine approaches in response to major issues related to tuberculosis.
Coordinated Action on Sexually Transmitted Infections (CA53)
This coordinated action was launched in 2022 to work on sexually transmitted infections (STIs) to improve prevention and diagnostic and therapeutic care.